"The Surprising Rise of a Generic Drug in Longevity Circles"

Rapamycin, a generic drug approved for transplant patients, has gained popularity as an anti-aging treatment despite lacking evidence of extending human life. The drug's potential to promote longevity is based on animal studies, but its off-label use for aging-related afflictions remains divisive among scientists and longevity influencers. While some believe in its potential, others caution about its side effects and the lack of conclusive evidence for human use. Despite regulatory limitations, more medical practices are prescribing rapamycin for anti-aging purposes, and telehealth companies are making it available to thousands of patients.